Although not a diagnostic criterion for basal cell nevus syndrome (BCNS, OMIM#109400), cutaneous cysts, particularly epidermoid cysts, are common in this condition. Cutaneous keratocysts, on the other hand, are extremely rare in general and have been identified in only 5 patients with BCNS. Here, we describe a BCNS patient with a cutaneous keratocyst that demonstrated D2-40 (podoplanin) immunoreactivity, which has been detected in odontogenic keratocysts but not cutaneous keratocysts. This finding suggests that cutaneous keratocysts may be developmentally homologous to odontogenic keratocysts and may behave similarly in terms of invasion and growth pattern.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1097/DAD.0000000000001638 | DOI Listing |
Semin Diagn Pathol
September 2024
Department of Oral & Maxillofacial Pathology and Oral Microbiology, King George's Medical University, Lucknow, India. Electronic address:
JAMA Dermatol
November 2024
Department of Dermatology, Perelman School of Medicine at the University of Pennsylvania, Philadelphia.
J Ultrasound Med
August 2024
Advanced Biomedical Sciences Department, University of Naples Federico II, Naples, Italy.
Turk Arch Pediatr
March 2024
Department of Dermatology and Venereology, İstanbul University İstanbul Faculty of Medicine, İstanbul, Turkey.
Curr Oncol
October 2023
School of Medicine, University of Nevada, Reno, NV 89557, USA.
Nevoid basal-cell carcinoma syndrome (Gorlin syndrome) is characterized by numerous cutaneous basal cell carcinomas mediated by mutations in the hedgehog pathway. Vismodegib or sonidegib represent promising treatment options. We identified 10 Gorlin patients who were treated with sonidegib ( = 6) or vismodegib ( = 4) between March 2012 and March 2022.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!